Systems and methods for implantable leadless tissue stimulation
US-9452286-B2 · Sep 27, 2016 · US
US12268463B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12268463-B2 |
| Application number | US-202318111499-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 17, 2023 |
| Priority date | Jul 7, 2016 |
| Publication date | Apr 8, 2025 |
| Grant date | Apr 8, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein is an implantable device configured to detect impedance characteristic of a tissue. In certain exemplary devices, the implantable device comprises (a) an ultrasonic transducer configured to emit an ultrasonic backscatter encoding information relating to an impedance characteristic of a tissue based on a modulated current flowing through the ultrasonic transducer; (b) an integrated circuit comprising (i) a variable frequency power supply electrically connected to a first electrode and a second electrode; (ii) a signal detector configured to detect an impedance, voltage, or current in a circuit comprising the variable frequency power supply, the first electrode, the second electrode, and the tissue; and (iii) a modulation circuit configured to modulate the current flowing through the ultrasonic transducer based on the detected impedance, voltage, or current; and the first electrode and the second electrode configured to be implanted into the tissue in electrical connection with each other through the tissue. Further described are systems including one or more implantable devices and an interrogator for operating the implantable device, methods of measuring impedance characteristic of a tissue in a subject, and methods of monitoring or characterizing a tissue in a subject.
Opening claim text (preview).
The invention claimed is: 1. A system comprising one or more implantable devices and an interrogator comprising one or more ultrasonic transducers configured to transmit ultrasonic waves to the one or more implantable devices or receive ultrasonic backscatter from the one or more implantable devices, the one or more implantable devices comprising a body 5 mm or less in length in the longest dimension, comprising: (a) an ultrasonic transducer configured to emit an ultrasonic backscatter encoding information relating to an impedance characteristic of a tissue at a plurality of different signal source frequencies based on a modulated current flowing through the ultrasonic transducer; and (b) an integrated circuit comprising: (i) a variable frequency signal source circuit electrically connected to a first electrode and a second electrode, wherein the first electrode and the second electrode are configured to be in electrical connection with each other through the tissue, and wherein the variable frequency signal source circuit is configured to apply a current or voltage through the tissue at the plurality of different signal source frequencies; (ii) a signal detector configured to detect, at the plurality of different signal source frequencies, an impedance, voltage, or current in a circuit comprising the variable frequency signal source circuit, the first electrode, the second electrode, and the tissue; and (iii) a modulation circuit configured to modulate the current flowing through the ultrasonic transducer to cause the ultrasonic transducer to emit the ultrasonic backscatter encoding the information comprising the impedance characteristic of the tissue at the plurality of different signal source frequencies. 2. A method of measuring an impedance characteristic of a tissue in a subject, comprising: receiving ultrasonic waves that power one or more implantable devices comprising an ultrasonic transducer; an integrated circuit comprising a source signal circuit and a signal detector configured to detect an impedance, voltage, or current; and a first electrode and a second electrode in electrical connection with each other through the tissue; converting energy from the ultrasonic waves into a first electrical current; transmitting the first electrical current to the integrated circuit; applying an electrical source signal through the tissue; detecting an impedance, voltage, or current of a circuit formed by the source signal circuit, the first electrode, the second electrode, and the tissue; modulating the first electrical current based on the detected impedance, voltage, or current; transducing the modulated first electrical current into an ultrasonic backscatter comprising information related to the impedance characteristic of the tissue encoded in the ultrasonic backscatter; and emitting the ultrasonic backscatter to an interrogator comprising one or more transducer configured to receive the ultrasonic backscatter. 3. The method of claim 2 , comprising: applying the electrical source signal through the tissue at a plurality of different source signal frequencies; and detecting the impedance, voltage, or current at the plurality of different source signal frequencies. 4. The method of claim 3 , wherein the information related to impedance comprises information related to impedance at the plurality of different source signal frequencies. 5. The method of claim 3 , comprising comparing the information related to the impedance characteristic of the tissue at the plurality of different source signal frequencies to a reference to characterize a tissue disease, an infection in the tissue, or a tissue injury. 6. The method of claim 3 , comprising: receiving ultrasonic backscatter comprising information related to impedance caused by the tissue at the plurality of different source signal frequencies at a first time point; receiving ultrasonic backscatter comprising information related to impedance caused by the tissue at the plurality of different source signal frequencies at a second time point; and comparing the information related to impedance caused by the tissue at the plurality of different source signal frequencies at the first time point and at the second time point to monitor a tissue disease, an infection in the tissue, or a tissue injury. 7. The method of claim 2 , wherein the signal detector is electrically connected to the first electrode and the second electrode. 8. The method of claim 2 , wherein the signal detector is electrically connected to a third electrode and a fourth electrode configured to detect the impedance, voltage, or current. 9. The method of claim 2 , wherein the source signal circuit is a variable frequency source signal circuit. 10. The method of claim 2 , comprising detecting the current or voltage, and determining the impedance based on the detected current or voltage. 11. The method of claim 2 , comprising determining an impedance magnitude and an impedance phase angle. 12. The method of claim 2 , comprising monitoring or characterizing the tissue during a healing process. 13. The method of claim 2 , wherein the tissue is bone, a bone fracture, or a soft tissue. 14. The method of claim 2 , wherein the method comprises monitoring or characterizing a bone fracture, a bone disease, scar tissue, or an ulcer. 15. The method of claim 2 , wherein the method comprises monitoring or characterizing a bone disease that causes pathological fracturing. 16. The method of claim 2 , wherein the method comprises monitoring or characterizing a tissue subject to compartment syndrome. 17. The method of claim 2 , wherein the method comprises monitoring or characterizing the tissue after a surgery. 18. The method of claim 2 , wherein the method comprises monitoring or characterizing a bone graft implant or spinal fusion. 19. The method of claim 2 , wherein the ultrasonic backscatter comprises a digitized signal. 20. A method of monitoring or characterizing a tissue a subject, comprising: transmitting ultrasonic waves from an interrogator comprising one or more ultrasonic transducers to one or more implantable devices comprising an ultrasonic transducer, an integrated circuit comprising a variable frequency source signal circuit and a signal detector configured to detect an impedance, voltage, or current; and a first electrode and a second electrode in electrical connection with each other through the tissue; receiving from the one or more implantable devices ultrasonic backscatter comprising information related to an impedance characteristic of the tissue at a plurality of different source signal frequencies encoded in the ultrasonic backscatter.
Arrangements in connection with the implantation of stimulators · CPC title
Biochemical electrodes {, e.g. electrical or mechanical details for in vitro measurements} · CPC title
operating with piezoelectric effect or with electrostriction (piezoelectric or electrostrictive devices per se H10N30/00) · CPC title
Neural system treatment · CPC title
for diagnosis of the brain · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.